To maintain their identity across generations, specialized cells must heritably repress swathes of genes — keeping active only genes necessary for the cell's purpose. Now it seems two repressive pathways join forces.
References
Viré, E. et al. Nature 439, 871–874 (2006).
Li, E. Nature Rev. Genet. 3, 662–673 (2002).
Kuzmichev, A., Jenuwein, T., Tempst, P. & Reinberg, D. Mol. Cell 14, 183–193 (2004).
Lund, A. H. & van Lohuizen, M. Curr. Opin. Cell Biol. 16, 239–246 (2004).
Ringrose, L. & Paro, R. Annu. Rev. Genet. 25, 413–434 (2004).
Yu-ichi, T. et al. Nature advance online publication doi:10.1038/nature04433 (2005).
Lehnertz, B. et al. Curr. Biol. 13, 1192–1200 (2003).
Hernández-Muñoz, I., Taghavi, P., Kuijl, C., Neefjes, J. & van Lohuizen, M. Mol. Cell. Biol. 25, 11047–11058 (2005).
Heard, E. Curr. Opin. Cell Biol. 16, 1–9 (2004).
Umlauf, D. et al. Nature Genet. 12, 1296–1300 (2004).
Lewis, A. et al. Nature Genet. 12, 1291–1295 (2004).
Yu-Wei, L. et al. Cancer Res. 64, 8184–8192 (2004).
Feldman, N. et al. Nature Cell Biol. advance online publication doi:10.1038/ncb1353 (2006).
Grace Goll, M. & Bestor, T. H. Annu. Rev. Biochem. 74, 481–514 (2005).
Marhold, J., Kramer, K., Kremmer, E. & Lyko, F. Development 131, 6033–6039 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taghavi, P., van Lohuizen, M. Two paths to silence merge. Nature 439, 794–795 (2006). https://doi.org/10.1038/439794a
Published:
Issue Date:
DOI: https://doi.org/10.1038/439794a
- Springer Nature Limited
This article is cited by
-
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
Clinical Epigenetics (2016)
-
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Oncogene (2008)